Supplementary Figure S3 from Paxalisib with Trastuzumab for HER2-Positive Metastatic Breast Cancer with Active Brain Metastases: A Phase II Trial with Integrated Plasma and CSF ctDNA Analyses

Authors:
Open Access
Publisher website
Google Scholar
Abstract
Longitudinal plasma tumor fraction (TF) dynamics in individual patients relative to changes in CNS target lesions assessed by RANO-BM criteria.